Sponsor
Prestige Biopharma Limited
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Prestige Biopharma Limited appears in 2 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
2 shownA Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer PatientsNCT03390686 · lead sponsor · 2019-11-15
ACTIVE_NOT_RECRUITINGA Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer PatientsNCT03013504 · lead sponsor · 2018-02-19
COMPLETEDSponsor roles
lead sponsor2
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.